Tech Center 1600 • Art Units: 1634 1655 1683
This examiner grants 12% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17472038 | COMPOSITIONS AND METHODS FOR DETECTING AN ABASIC SITE | Non-Final OA | ILLUMINA, INC. |
| 17289889 | NUCLEIC ACID-BASED BARCODING | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18269634 | CLEAVAGE OF CAPTURE PROBES FOR SPATIAL ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18120024 | CONCATEMERIC DETECTABLE PROBES AND RELATED METHODS | Non-Final OA | 10x Genomics, Inc. |
| 18046457 | COMPOSITIONS AND METHODS FOR USE WITH FIXED SAMPLES | Non-Final OA | 10x Genomics, Inc. |
| 19249209 | METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM | Non-Final OA | QUORUM INNOVATIONS,INC. |
| 19034863 | AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR | Non-Final OA | Akouos, Inc. |
| 17147151 | METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 18606200 | CONSTRUCTS, USE AND METHODS THEREOF | Non-Final OA | SUNNYBROOK RESEARCH INSTITUTE |
| 19018613 | Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine | Non-Final OA | Mammal Labs LLC |
| 18035319 | MODIFIED ANTISENSE OLIGONUCLEOTIDES TARGETING SPLICING FACTORS | Non-Final OA | The Jackson Laboratory |
| 18021861 | DETECTING NON-HODGKIN LYMPHOMA | Non-Final OA | Exact Sciences Corporation |
| 16629204 | Risk Assessment Tool for Patients with Sepsis | Non-Final OA | McMaster University |
| 18040066 | Characterising Macrophages and Methods Thereof | Non-Final OA | Agency for Science, Technology and Research |
| 17806099 | DETECTION METHOD | Final Rejection | TOPPAN Inc. |
| 18806201 | Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor | Non-Final OA | Canon Medical Diagnostics Corporation |
| 18134125 | Method of Treating Liver Cancer, Predicting Response to Treatment, and Predicting Adverse Effects During the Treatment Thereof | Non-Final OA | Singapore Health Services Pte Ltd |
| 17172527 | METHODS AND COMPOSITIONS FOR MESSENGER RNA PURIFICATION | Non-Final OA | Translate Bio, Inc. |
| 18261537 | METHODS FOR EVALUATION OF EARLY STAGE ORAL SQUAMOUS CELL CARCINOMA | Non-Final OA | LOMA LINDA UNIVERSITY |
| 18001805 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | Non-Final OA | STEALTH LABELS BIOTECH AB |
| 17951874 | TISSUE HOMOGENIZATION BUFFER FOR EFFICIENT QUANTITATION OF A THERAPEUTIC OLIGONUCLEOTIDE IN MULTIPLE TISSUES | Non-Final OA | TriSalus Life Sciences, Inc. |
| 18337000 | DNA METHELATION MOLECULAR MARKERS FOR IDENTIFYING BENIGNITY OR MALIGNANCY OF LUNG NODULE AND APPLICATIONS OF THE SAME | Non-Final OA | AnchorDx Medical Co., Ltd. |
| 17312262 | METHOD FOR MEASURING TELOMERE ASSOCIATED VARIABLES AND USES THEREOF FOR THE DIAGNOSIS AND/OR PROGNOSIS OF TELOMERIC-ASSOCIATED DISEASES | Non-Final OA | LIFE LENGTH, S.L. |
| 16918958 | HIGH CAPACITY MOLECULE DETECTION | Final Rejection | Davinci Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy